Cellular/Molecular
Reversible Suppression of Glutamatergic Neurotransmission of Cerebellar Granule Cells In Vivo by Genetically Manipulated Expression of Tetanus Neurotoxin Light Chain
Mutsuya Yamamoto, Norio Wada, Yasuji Kitabatake, Dai Watanabe, Masayuki Anzai, Minesuke Yokoyama, Yutaka Teranishi and Shigetada Nakanishi
Journal of Neuroscience 30 July 2003, 23 (17) 6759-6767; DOI: https://doi.org/10.1523/JNEUROSCI.23-17-06759.2003
Mutsuya Yamamoto
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Norio Wada
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Yasuji Kitabatake
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Dai Watanabe
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Masayuki Anzai
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Minesuke Yokoyama
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Yutaka Teranishi
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Shigetada Nakanishi
1Mitsubishi Pharma Corporation, Discovery Technology Laboratory, Yokohama, 227-0033, Japan,
2Department of Molecular and System Biology, Kyoto University Graduate School of Biostudies, Kyoto, 606-8501, Japan,
3Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto, 606-8501, Japan,
4GenCom Corporation, Machida, 194-8511, Japan, and
5Mitsubishi Kagaku Institute of Life Sciences, Machida, 194-8511, Japan
Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 23, Issue 17
30 Jul 2003
Reversible Suppression of Glutamatergic Neurotransmission of Cerebellar Granule Cells In Vivo by Genetically Manipulated Expression of Tetanus Neurotoxin Light Chain
Mutsuya Yamamoto, Norio Wada, Yasuji Kitabatake, Dai Watanabe, Masayuki Anzai, Minesuke Yokoyama, Yutaka Teranishi, Shigetada Nakanishi
Journal of Neuroscience 30 July 2003, 23 (17) 6759-6767; DOI: 10.1523/JNEUROSCI.23-17-06759.2003
Reversible Suppression of Glutamatergic Neurotransmission of Cerebellar Granule Cells In Vivo by Genetically Manipulated Expression of Tetanus Neurotoxin Light Chain
Mutsuya Yamamoto, Norio Wada, Yasuji Kitabatake, Dai Watanabe, Masayuki Anzai, Minesuke Yokoyama, Yutaka Teranishi, Shigetada Nakanishi
Journal of Neuroscience 30 July 2003, 23 (17) 6759-6767; DOI: 10.1523/JNEUROSCI.23-17-06759.2003
Jump to section
Keywords
Responses to this article
Jump to comment:
No eLetters have been published for this article.